News

• 6 Nov, 2024
  Spago Nanomedical delårsrapport januari-september 2024
• 6 Nov, 2024
  Spago Nanomedical interim report January-September 2024
• 21 Oct, 2024
  Valberedning utsedd inför Spago Nanomedicals årsstämma 2025
• 21 Oct, 2024
  Nomination committee appointed for Spago Nanomedical’s Annual General Meeting 2025
• 1 Oct, 2024
  Spago Nanomedical i ny fas med fullt fokus på Tumorad-programmet
• 1 Oct, 2024
  Spago Nanomedical in new phase with full focus on the Tumorad program
• 27 Aug, 2024
  Spago Nanomedicals fas I/IIa-studie Tumorad-01 fortsätter efter framgångsrikt slutförd behandling av första patientgruppen
• 27 Aug, 2024
  Spago Nanomedical’s Phase I/IIa study Tumorad-01 continues following successful treatment completion of first patient group
• 21 Aug, 2024
  Spago Nanomedical delårsrapport januari-juni 2024
• 21 Aug, 2024
  Spago Nanomedical interim report January-June 2024